Neuronetics (FRA:NRC) Additional Paid-In Capital : €375.95 Mil(As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Neuronetics Additional Paid-In Capital?

Neuronetics's quarterly additional paid-in capital increased from Jun. 2023 (€375.20 Mil) to Sep. 2023 (€382.63 Mil) but then stayed the same from Sep. 2023 (€382.63 Mil) to Dec. 2023 (€375.95 Mil).

Neuronetics's annual additional paid-in capital increased from Dec. 2021 (€348.38 Mil) to Dec. 2022 (€380.13 Mil) but then declined from Dec. 2022 (€380.13 Mil) to Dec. 2023 (€375.95 Mil).

Neuronetics Additional Paid-In Capital Historical Data

The historical data trend for Neuronetics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuronetics Additional Paid-In Capital Chart

Neuronetics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

267.98

248.94

348.38

380.13

375.95

Neuronetics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															380.13	377.78	375.20	382.63	375.95

Neuronetics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Neuronetics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Neuronetics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Neuronetics (FRA:NRC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Neuronetics Inc (FRA:NRC) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

STIM:USA NRC:Germany

Address

3222 Phoenixville Pike, Malvern, PA, USA, 19355

Website

https://www.neurostar.com

Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.